Brief: DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the U.S. Sales of Veligrotug and VRDN-003 for the Treatment of Thyroid Eye Disease (TED)

DRI Healthcare Trust

20/10/2025 12:52

Oct 20 (Reuters) - Dri Healthcare Trust DHT_u.TO:

DRI HEALTHCARE TRUST ANNOUNCES ACQUISITION OF A SYNTHETIC ROYALTY INTEREST IN THE U.S. SALES OF VELIGROTUG AND VRDN-003 FOR THE TREATMENT OF THYROID EYE DISEASE (TED)

DRI HEALTHCARE TRUST - TO PAY $55 MILLION UPFRONT, $300 MILLION TOTAL INVESTMENT

Source text: ID:nCNWlvQV2a

Further company coverage: [DHT_u.TO]

 ((Reuters.Briefs@thomsonreuters.com))